We highlighted the presence of specific mutational signatures (COSMIC signature 3) (33) and genomic instability characteristics (LOH, TAI and LST) (34–36), reflecting significant HRD, comparable with that observed in ovarian cancers with a BRCA1 or BRCA2 pathogenic variants. The gene discussed is BRCA2; the disease is ovarian carcinoma.